Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Temsirolimus (CCI-779)
DRUG
2 trials
Sponsors
Pfizer
Conditions
Advanced Renal Cell Carcinoma
Lymphoma
Phase 2
Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma
Completed
NCT00494091
Pfizer
Advanced Renal Cell Carcinoma
Start: 2007-02-28
End: 2012-03-31
Updated: 2013-03-21
Phase 3
Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
Completed
NCT00117598
Pfizer
Lymphoma
Start: 2005-05-31
End: 2011-01-31
Updated: 2015-03-30
Related Papers
Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis.
2015-04-11
5 citations